Stereotaxis (NYSE: STXS) is purchasing a Minneapolis-based electrophysiology (EP) catheter maker to further enhance its minimally invasive endovascular surgical robotics technology. St. Louis–based Stereotaxis did not disclose how much it is paying for Access Point Technologies in its after-hours news release. The transaction, paid with … [Read more...] about Stereotaxis to acquire Access Point Technologies and its EP catheters
Stereotaxis
The top catheter-based innovation news stories of 2024 — so far
Catheter innovations have had a remarkable year so far, with many receiving regulatory approval as they prepare to enter the market. The pulsed field ablation market heated up in 2023 and continues to make waves this year with more companies entering the space. Intravascular lithotripsy is having its moment as well – Shockwave Medical was … [Read more...] about The top catheter-based innovation news stories of 2024 — so far
Stereotaxis submits Magic ablation catheter for U.S., European approval
Stereotaxis (NYSE:STXS) announced that it submitted its Magic ablation catheter for both European and U.S. regulatory approval. The company said its FDA and CE mark submissions follow successful clinical results in an ongoing trial. Last month, Stereotaxis announced the first Magic treatments in the European trial supporting its submissions. … [Read more...] about Stereotaxis submits Magic ablation catheter for U.S., European approval
First patients treated using Stereotaxis MAGiC ablation catheter
Stereotaxis today announced the first patients have been successfully treated using its MAGiC magnetic interventional ablation catheter. The MAGiC catheter is a robotically navigated magnetic ablation catheter that performs minimally invasive cardiac ablation procedures. The first procedures were performed in Lithuania in eight patients … [Read more...] about First patients treated using Stereotaxis MAGiC ablation catheter
Stereotaxis submits robotically navigated ablation catheter for CE mark
Stereotaxis (NYSE:STXS) announced today that it submitted its MAGiC catheter for CE mark approval in Europe. The St. Louis-based company designed MAGiC as a robotically navigated, magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures. Used in conjunction with Stereotaxis' robotic systems, the catheter … [Read more...] about Stereotaxis submits robotically navigated ablation catheter for CE mark
Stereotaxis opens new headquarters in St. Louis
Surgical robotics company Stereotaxis (NYSE: STXS) is holding a grand opening today for its 45,000 ft² headquarters facility in downtown St. Louis. The new headquarters is located in the renovated historic Globe Building in St. Louis’s growing Downtown North Urban Insight District. It's an all-in-one facility housing research and development, … [Read more...] about Stereotaxis opens new headquarters in St. Louis
Study: Stereotaxis robotic technology reduces silent cerebral embolism during AFib ablation
Stereotaxis announced the positive results from a study of its robotic magnetic navigation system in atrial fibrillation ablation. The multi-center, prospective study evaluated 166 patients with paroxysmal or persistent AFib who underwent pulmonary vein isolation using Stereotaxis' robotic magnetic navigation (RMN) technology or manual contact … [Read more...] about Study: Stereotaxis robotic technology reduces silent cerebral embolism during AFib ablation
Stereotaxis touts positive results in robotic cardiac ablation study
Stereotaxis this week announced positive outcomes of an independent study assessing its robotic cardiac ablation system in pediatric patients. The St. Louis-based company's robotic technology demonstrated superior safety and efficacy in treating atrioventricular reentry tachycardia (AVRT) and atrioventricular nodal reentry tachycardia (AVNRT) in … [Read more...] about Stereotaxis touts positive results in robotic cardiac ablation study
Stereotaxis forms partnership to advance electrophysiology robotics in China
Stereotaxis this week announced it has forged a broad collaboration with Shanghai Microport EP Medtech to advance technology innovation and commercial adoption of electrophysiology robotics in China. The agreement combines MicroPort EP's commercial and product expertise in China's electrophysiology market and Sterotaxis's Robotic Magnetic … [Read more...] about Stereotaxis forms partnership to advance electrophysiology robotics in China
